Key Points
This week the FDA approved an updated version of a COVID-19 vaccine from Novavax.This shot is effective at preventing infection with Omicron strains of the virus.For some, the Novavax vaccine may have fewer side effects compared to mRNA vaccines...
On October 3, the Food and Drug Administration (FDA) authorized the use of a new, updated vaccine from Novavax against COVID-19 variants...
The protein-based Novavax vaccine will join the ranks of the recently updated mRNA vaccines from Pfizer and Moderna...
Although protein and mRNA vaccines work differently, they are both effective at preventing COVID-19 infection and severe illness...
John Moore, a virologist at Cornell University's Weill Cornell Medicine in New York told USA Today that the body produces a similar amount of neutralizing antibodies regardless of the types of vaccines...
You might be interested in
Novavax exec says its new COVID shot should work against variants on the rise
06, Jun, 23Novavax Inc's head of research and development on Monday said an updated COVID-19 vaccine the company is already producing is likely to be protective against other fast-growing coronavirus variants circulating in the U.S.